The Use of Cannabis by Patients with Sickle Cell Disease Increased the Frequency of Hospitalization due to Vaso-Occlusive Crises

被引:18
|
作者
Ballas, Samir K. [1 ]
机构
[1] Thomas Jefferson Univ, Dept Med, Sidney Kimmel Med Coll, Cardeza Fdn Hematol Res, 1020 Locust St, Philadelphia, PA 19107 USA
关键词
cannabinoid; cannabis; sickle cell disease; VOC;
D O I
10.1089/can.2017.0011
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: The objective of this study was to determine if patients with sickle cell disease using cannabis had decreased frequency of acute vaso-occlusive crises (VOCs) that required hospitalization. Method: This was a retrospective study in which 270 urine drug screen tests were done on 72 patients: 40 males and 32 females. Results: Cannabinoids were found in 144 urine tests from 37 patients and were negative in 126 tests from 35 patients. Males who used cannabis were significantly younger (p0.001) than males who did not. Patients who tested positive used benzodiazepines, cocaine, and phencyclidine significantly more often than patients who tested negative. There was no significant difference in the amounts of opioids consumed by users and nonusers of cannabis. The cannabis cohort was seen in the clinic significantly (p0.05) less often than controls, but hospital admissions were significantly greater in the cannabis group than controls (p0.05). Conclusion: These data show an unexpected negative effect of cannabis on the frequency of VOCs. This may be due to the effect of cannabis on the brain and/or the severity of the disease in the cannabis users. More controlled studies are needed to clarify these findings.
引用
收藏
页码:197 / 201
页数:5
相关论文
共 50 条
  • [31] DECREASED FREQUENCY OF VASO-OCCLUSIVE CRISES ASSOCIATED WITH INTRAVENOUS IMMUNE GLOBULIN IN A PATIENT WITH SICKLE CELL DISEASE
    Cooper, James
    Gunawardena, Sriya
    Krishnamurti, Lakshmanan
    PEDIATRIC BLOOD & CANCER, 2010, 54 (06) : 838 - 838
  • [32] Frequency of vaso-occlusive crises among patients with severe sickle cell disease receiving standard-of-care treatment
    Titievsky, Lina
    Manjelievskaia, Janna
    Ender, Katherine L.
    Shi, Daoyuan
    Lillehaugen, Timothy
    Beukelman, Timothy
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 85 - 85
  • [33] Treatment of uncomplicated vaso-occlusive crises in children with sickle cell disease in a day hospital
    Raphael, Jean L.
    Kamdar, Aditi
    Beavers, M. Brooke
    Mahoney, Donald H.
    Mueller, Brigitta U.
    PEDIATRIC BLOOD & CANCER, 2008, 51 (01) : 82 - 85
  • [34] OPTIMIZATION OF PAIN MANAGEMENT STRATEGIES IN CHILDREN WITH SICKLE CELL DISEASE AND VASO-OCCLUSIVE CRISES
    LeBlanc, Dana
    Velez, Maria
    Gardner, Renee
    PEDIATRIC BLOOD & CANCER, 2015, 62 : 46 - 46
  • [35] Contemporary Management and Prevention of Vaso-Occlusive Crises (VOCs) in Adults With Sickle Cell Disease
    Weaver, Salome Bwayo
    Rungkitwattanakul, Dhakrit
    Singh, Divita
    JOURNAL OF PHARMACY PRACTICE, 2023, 36 (01) : 139 - 148
  • [37] FRESH-FROZEN PLASMA FOR VASO-OCCLUSIVE CRISES IN SICKLE-CELL DISEASE
    HUEHNS, ER
    DAVIES, SC
    BROZOVIC, M
    LANCET, 1981, 1 (8233): : 1310 - 1311
  • [38] HEALTHCARE RESOURCE UTILIZATION AMONG PATIENTS WITH SICKLE CELL DISEASE WITH RECURRENT VASO-OCCLUSIVE CRISES IN ENGLAND
    Udeze, C.
    Ly, N. F.
    Ingleby, F. C.
    Fleming, S. D.
    Conner, S.
    Howard, J.
    Li, N.
    Shah, F.
    VALUE IN HEALTH, 2023, 26 (06) : S156 - S156
  • [39] Vaso-occlusive crises and HELLP syndrome in a patient with sickle cell hemoglobin C disease
    Guimbi, Kryste Chancel Mahoungou
    Kouame, Edmond Konan
    Azougagh, Khalid
    Rea, Didier
    Mfam, Willy Serge
    ANESTHESIE & REANIMATION, 2015, 1 (03): : 256 - 258
  • [40] Nitric oxide: A potential etiological agent for vaso-occlusive crises in sickle cell disease
    Gupta, Parul
    Kumar, Ravindra
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2024, 144 : 40 - 46